Modafinil Research and Experience: The Pages, the Sources and the Ground Rules

This hub brings together modafinil research and experience: sourced summaries of the published studies, covering military aviation trials, shift-work and sleep trials, cognition reviews and the gaps in long-term safety data, each set against one long-term user's first-hand notes. These pages must contain no sales pitches and no dosing advice. The hub covers what the research supports, what it leaves open, and what one long-term user noticed along the way.

Personal account, not medical advice. Modafinil is a prescription medicine, and a Schedule IV controlled substance in the United States. Nothing here is a recommendation to start, stop or change anything. Talk to a doctor.

Long-term use

• Modafinil withdrawal symptoms: what stopping looks like in the published sources.

Comparisons

• Modafinil vs armodafinil: the isomer research and the shared effects.
• Modafinil vs caffeine: the sleep-deprivation studies, and what interaction checkers say about combining them.

Performance and cognition

• Benefits of modafinil: which benefits have the strongest evidence, and where it is weak.
• Modafinil as a nootropic: the healthy-person cognition studies.

Sleep, shifts and fatigue

• Modafinil for idiopathic hypersomnia: the trials behind its use in idiopathic hypersomnia, and what they leave open.
• Modafinil for night shift workers: the shift-work trial, and the alert-versus-rested trade.

Military and aviation

• Go pills in the Air Force: what the Air Force's "go pills" are and the rules around when they can be used.

The honest overview

• Modafinil pros and cons: the balanced ledger, with every row tagged as research or experience.

How these pages are written

Research first, experience second. Every research claim on the linked pages must trace to that page's own source list, so a reader can check it, and be machine-checked before publication. Where the research is thin or mixed, the pages must say so rather than fill the gap. Research and experience must stay distinct: first-hand notes are written in the first person as one person's account. The first-hand notes belong to one person, The Night Owl, a long-term user of modafinil who is not a doctor. The writing is anonymous. Nothing on these pages is medical advice.

What these pages will not do: recommend that anyone take, stop or change a prescription medicine, or explain how to obtain one.

Written by The Night Owl, a long-term user of modafinil who is not a doctor, pharmacist or healthcare provider. This page describes one person's experience alongside published research. It is not medical advice.

Sources

No external sources are cited on this index page.